INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
USA - NYSE:INSP - US4577301090 - Common Stock
79.88 USD
-3.52 (-4.22%)
79.88 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to INSP. INSP was compared to 191 industry peers in the Health Care Equipment & Supplies industry. INSP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. INSP is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, INSP could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
In the past year INSP was profitable.
INSP had a positive operating cash flow in the past year.
In the past 5 years INSP reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: INSP reported negative operating cash flow in multiple years.
1.2 Ratios
INSP's Return On Assets of 6.62% is amongst the best of the industry. INSP outperforms 86.39% of its industry peers.
Looking at the Return On Equity, with a value of 7.84%, INSP belongs to the top of the industry, outperforming 81.15% of the companies in the same industry.
INSP's Return On Invested Capital of 5.35% is fine compared to the rest of the industry. INSP outperforms 78.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.62% | ||
| ROE | 7.84% | ||
| ROIC | 5.35% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
INSP has a better Profit Margin (6.17%) than 77.49% of its industry peers.
Looking at the Operating Margin, with a value of 4.81%, INSP is in the better half of the industry, outperforming 69.63% of the companies in the same industry.
INSP has a Gross Margin of 84.47%. This is amongst the best in the industry. INSP outperforms 94.24% of its industry peers.
INSP's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.81% | ||
| PM (TTM) | 6.17% | ||
| GM | 84.47% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
INSP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for INSP has been increased compared to 1 year ago.
Compared to 5 years ago, INSP has more shares outstanding
There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
INSP has an Altman-Z score of 12.85. This indicates that INSP is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 12.85, INSP belongs to the top of the industry, outperforming 93.19% of the companies in the same industry.
There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 12.85 |
ROIC/WACC0.61
WACC8.78%
2.3 Liquidity
A Current Ratio of 6.14 indicates that INSP has no problem at all paying its short term obligations.
With an excellent Current ratio value of 6.14, INSP belongs to the best of the industry, outperforming 81.68% of the companies in the same industry.
A Quick Ratio of 4.84 indicates that INSP has no problem at all paying its short term obligations.
The Quick ratio of INSP (4.84) is better than 80.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.14 | ||
| Quick Ratio | 4.84 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 1177.78% over the past year.
INSP shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.05%.
The Revenue has been growing by 57.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.63%
Revenue 1Y (TTM)22.05%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.82%
3.2 Future
INSP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.47% yearly.
The Revenue is expected to grow by 14.28% on average over the next years. This is quite good.
EPS Next Y-70.47%
EPS Next 2Y-5%
EPS Next 3Y14.99%
EPS Next 5Y26.47%
Revenue Next Year13.1%
Revenue Next 2Y13.73%
Revenue Next 3Y14.08%
Revenue Next 5Y14.28%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 34.73, which means the current valuation is very expensive for INSP.
INSP's Price/Earnings ratio is a bit cheaper when compared to the industry. INSP is cheaper than 71.73% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.38, INSP is valued a bit more expensive.
A Price/Forward Earnings ratio of 51.17 indicates a quite expensive valuation of INSP.
Based on the Price/Forward Earnings ratio, INSP is valued a bit cheaper than 68.59% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, INSP is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.73 | ||
| Fwd PE | 51.17 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, INSP is valued a bit cheaper than 69.63% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of INSP indicates a rather cheap valuation: INSP is cheaper than 81.68% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.79 | ||
| EV/EBITDA | 35.78 |
4.3 Compensation for Growth
INSP's earnings are expected to grow with 14.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5%
EPS Next 3Y14.99%
5. Dividend
5.1 Amount
No dividends for INSP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
79.88
-3.52 (-4.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners114.52%
Inst Owner Change-1.82%
Ins Owners0.94%
Ins Owner Change0.31%
Market Cap2.36B
Analysts75.38
Price Target148.19 (85.52%)
Short Float %8.74%
Short Ratio2.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)127.01%
Min EPS beat(2)114.53%
Max EPS beat(2)139.49%
EPS beat(4)4
Avg EPS beat(4)247.35%
Min EPS beat(4)54.07%
Max EPS beat(4)681.29%
EPS beat(8)8
Avg EPS beat(8)257.08%
EPS beat(12)12
Avg EPS beat(12)187.32%
EPS beat(16)16
Avg EPS beat(16)150.49%
Revenue beat(2)1
Avg Revenue beat(2)0.22%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)1.13%
Revenue beat(4)2
Avg Revenue beat(4)0.1%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)-0.06%
Revenue beat(12)8
Avg Revenue beat(12)2.61%
Revenue beat(16)12
Avg Revenue beat(16)3.81%
PT rev (1m)-16.71%
PT rev (3m)-32.96%
EPS NQ rev (1m)-256.31%
EPS NQ rev (3m)-135.88%
EPS NY rev (1m)0%
EPS NY rev (3m)-77.9%
Revenue NQ rev (1m)-0.64%
Revenue NQ rev (3m)-7.99%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-4.73%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.73 | ||
| Fwd PE | 51.17 | ||
| P/S | 2.74 | ||
| P/FCF | 27.79 | ||
| P/OCF | 20.11 | ||
| P/B | 3.48 | ||
| P/tB | 3.48 | ||
| EV/EBITDA | 35.78 |
EPS(TTM)2.3
EY2.88%
EPS(NY)1.56
Fwd EY1.95%
FCF(TTM)2.87
FCFY3.6%
OCF(TTM)3.97
OCFY4.97%
SpS29.13
BVpS22.92
TBVpS22.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.62% | ||
| ROE | 7.84% | ||
| ROCE | 5.84% | ||
| ROIC | 5.35% | ||
| ROICexc | 9.29% | ||
| ROICexgc | 9.29% | ||
| OM | 4.81% | ||
| PM (TTM) | 6.17% | ||
| GM | 84.47% | ||
| FCFM | 9.87% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
F-Score7
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 300.74% | ||
| Cap/Sales | 3.77% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 225.05% | ||
| Profit Quality | 160.03% | ||
| Current Ratio | 6.14 | ||
| Quick Ratio | 4.84 | ||
| Altman-Z | 12.85 |
F-Score7
WACC8.78%
ROIC/WACC0.61
Cap/Depr(3y)638.93%
Cap/Depr(5y)518.49%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.63%
EPS Next Y-70.47%
EPS Next 2Y-5%
EPS Next 3Y14.99%
EPS Next 5Y26.47%
Revenue 1Y (TTM)22.05%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.82%
Revenue Next Year13.1%
Revenue Next 2Y13.73%
Revenue Next 3Y14.08%
Revenue Next 5Y14.28%
EBIT growth 1Y389.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year687.25%
EBIT Next 3Y123.87%
EBIT Next 5Y79.05%
FCF growth 1Y348.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y245.22%
OCF growth 3YN/A
OCF growth 5YN/A